HemaCare Corp. Supports Cell & Gene Meeting On The Mesa
LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation (OTCBB:HEMA), a leader in cell and tissue collection, processing, and cell therapy solutions, today announced that it is supporting the 2016 Cell and Gene Meeting on the Mesa to be held at the Estancia Hotel and the Salk Institute in La Jolla, October 5th-7th. This meeting is organized by the Alliance for Regenerative Medicine in partnership with the Sanford Consortium for Regenerative Medicine and is the premier annual meeting, bringing together over 800 cell therapy key opinion leaders, scientific researchers from academia and industry, industry decision-makers, clinical leaders and patient advocates. The focus of this meeting is to collaborate on the development and clinical trial testing of therapies utilizing various cell and gene-modification technologies to advance the delivery of these therapies to patients for the treatment of a wide range of diseases.